Correlation Between Royalty Pharma and Prime Medicine,
Can any of the company-specific risk be diversified away by investing in both Royalty Pharma and Prime Medicine, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Royalty Pharma and Prime Medicine, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Royalty Pharma Plc and Prime Medicine, Common, you can compare the effects of market volatilities on Royalty Pharma and Prime Medicine, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Royalty Pharma with a short position of Prime Medicine,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Royalty Pharma and Prime Medicine,.
Diversification Opportunities for Royalty Pharma and Prime Medicine,
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Royalty and Prime is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Royalty Pharma Plc and Prime Medicine, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prime Medicine, Common and Royalty Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Royalty Pharma Plc are associated (or correlated) with Prime Medicine,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prime Medicine, Common has no effect on the direction of Royalty Pharma i.e., Royalty Pharma and Prime Medicine, go up and down completely randomly.
Pair Corralation between Royalty Pharma and Prime Medicine,
Given the investment horizon of 90 days Royalty Pharma Plc is expected to generate 0.23 times more return on investment than Prime Medicine,. However, Royalty Pharma Plc is 4.43 times less risky than Prime Medicine,. It trades about -0.1 of its potential returns per unit of risk. Prime Medicine, Common is currently generating about -0.26 per unit of risk. If you would invest 2,704 in Royalty Pharma Plc on August 27, 2024 and sell it today you would lose (61.00) from holding Royalty Pharma Plc or give up 2.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Royalty Pharma Plc vs. Prime Medicine, Common
Performance |
| Timeline |
| Royalty Pharma Plc |
| Prime Medicine, Common |
Royalty Pharma and Prime Medicine, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Royalty Pharma and Prime Medicine,
The main advantage of trading using opposite Royalty Pharma and Prime Medicine, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Royalty Pharma position performs unexpectedly, Prime Medicine, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prime Medicine, will offset losses from the drop in Prime Medicine,'s long position.| Royalty Pharma vs. Prime Medicine, Common | Royalty Pharma vs. Ginkgo Bioworks Holdings | Royalty Pharma vs. Ocean Biomedical | Royalty Pharma vs. Adaptive Biotechnologies Corp |
| Prime Medicine, vs. Beam Therapeutics | Prime Medicine, vs. Caribou Biosciences | Prime Medicine, vs. Intellia Therapeutics | Prime Medicine, vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |